Chemical formula: C₂₉H₃₃FN₂O₄ Molecular mass: 492.582 g/mol PubChem compound: 10077130
Vorapaxar is indicated for:
Population group: only adults (18 years old or older)
Vorapaxar is indicated for the reduction of atherothrombotic events in adult patients with a history of myocardial infarction (MI), co-administered with acetylsalicylic acid (ASA) and, where appropriate, clopidogrel.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Vorapaxar is indicated for the reduction of atherothrombotic events in adult patients with symptomatic peripheral arterial disease (PAD), co-administered with acetylsalicylic acid (ASA) or, where appropriate, clopidogrel.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Vorapaxar is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.